Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Join Sandoz, Sanofi, Boehringer Ingelheim, Mundipharma and more at Biosimilars and BiobettersSMi's 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will cover regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and global market developments.
By: SMi Group • 16 case studies from leading industry players including Merck Serono, Teva, Cinfa Biotech GmbH, MHRA and many more • Interactive panel debate to assess the sustainability of Biosimilars and Biobetters market in Europe • 2 workshops on regulatory developments and understanding commerciality • 3hrs+ networking time with 70+ selected Biosimilars/ Network with a global audience of leading scientists and key decision makers in the Biosimilars and Biobetters arena. Confirmed attendees include: AbbVie, Alston & Bird LLP, Anteris Medical GmbH, Arnold & Porter LLP, Boehringer Ingelheim, Bristows LLP, Cinfa Biotech GmbH, Ecole Normale Supérieure de Cachan, Eppendorf, Fresenius Kabi, GfK, Grifols, Harvest Moon Pharmaceuticals, IMS Health UK, Italfarmaco S.p.A., Kantar Health, Kinesys Consulting, Merck Serono, MHRA, Mundipharma, Norwegian Medicines Agency, SAI MedPartners, Sandoz International GmbH, Sanofi, Selecta Biosciences, SGS Life Science Services, SGS M-Scan Ltd, Teva, University of Basel, Venner Shipley LLP plus many more... Featured speakers include: Richard DiCicco, Chairman, Harvest Moon Pharmaceuticals USA, Inc. Shahin Kauser, Senior Scientific Assessor, MHRA Chris Teale, Vice President Europe, GfK NOP Ltd Bracha Timan, Director, Israel Site Head, Global Bioassays & Technology, Global R&D, Teva Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences Karsten Roth, Director Clinical Operations, Cinfa Biotech GmbH Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health Steinar Madsen, Medical Director, Norwegian Medicines Agency To view the full speaker line-up and conference programme, visit http://www.smi- Plus, don't miss two interactive conference workshops on: Assessing the Regulatory Framework for Europe and the US – Developing Future Biologics Workshop Leaders: Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP | 1:00pm - 5.30pm, 29th September 2015 Biosimilars - Understanding the Regulatory Processes and the Commercial Realities Workshop Leader: Peter Wittner, Senior Consultant, Interpharm Consultancy | 8:30am - 12.30pm, 2nd October 2015 End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|